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Because enzymes are among the most important regulators of animal and 
plant life processes, the results of the ability to control and utilize them may 
well prove to be far reaching.  Such control and utilization can only follow an 
understanding of their mode of action, and of the  conditions affecting their 
activity. 
One of the most important and best studied groups of organic catalysts is 
the proteolytic enzymes. 
A. CLASSIFICATION 
Proteolytic  enzymes, or proteases,  are those  enzymes which break down 
protein  by  hydrolyzing  peptide  linkages. The  work of  Bergmann and  his  co- 
workers (1936,  1937)  has demonstrated that  two general  classes  of  protease.s 
can  be  differentiated,  the  proteinases  and the  peptidases. 
Proteinases  hydrolyze peptide  linkages  anywhere in the  protein  molecule. 
Usually the  linkages  are  within  the  molecule,  i.e.  adjacent  to  another  peptide 
bond,  so  that  these  enzymes  have  been  called  "endopeptidases."  They  may  be 
further  classified  on  the  basis  of  animal  or  plant  origin,  extracellular  or  intra- 
cellular  action,  optimal  action  at  neutral  pll  or  in  varying degrees  of  acidity, 
and activation  or inactivation  hy various  compounds.  The extraceUular 
proteinases  include  pepsin  (active  in  acid  medium),  trypsin  and  chymotrypsin 
(most  active  in  neutral  or  slightly  alkaline  medium), and some yeast,  mold, 
and  bacterial  proteases. The  intracellular  proteinases  include  those  of  animal 
origin,  called  cathepsins  (found in  all  tissues  and organs,  and most active  in 
acid  medium at  pH 5 to  6),  and  those  of  plant  origin,  including  papain (from 
the  papaya plant,  optimum pH 5  to  6),  ficin  (from  figs),  bromelin (from pine- 
apple),  most  yeast  and  mold  proteases,  and  most  bacterial  proteases. Leuco- 
protease,  the  proteolytic  enzyme of  white blood cells  (most active  at neutral 
pH), probably functions within as well as outside of the cells, but because its 
properties are similar to those of trypsin it has  usually been classified with 
this extracellular enzyme. 
Peptidases hydrolyze only peptide linkages that are adjacent to the end of 
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the protein molecule, and have therefore been called "exopeptidases."  They 
may be classified on the same bases as the proteinases, and are as widely dis- 
tributed.  Both proteinases and peptidases,  especially the latter, have been 
further classified in terms of the specificity of the substrate that is hydrolyzed. 
Thus,  carboxypeptidases  hydrolyze  substrates  with  a  free  carboxyl  group 
adjacent to the linkage to be split, aminopeptidases hydrolyze substrates with 
a  free amino group, and dipeptidases,  substrates  with a free carboxyl  and a 
free amino group. 
B. CONDITIONS  AFFECTING THE ACTIVITY  OF PROTEOLYTIC  ENZYMES 
(REVIEW OF LI~E~ATUP.E) 
The influence of temperature and of hydrogen ion concentration on the activity of 
proteolytic enzymes has been  carefully studied.  Most of these enzymes are very 
active at 37°C.,  slightly increased  in activity by short exposure to a  temperature 
between 37 and 60°C.,  slightly impaired by a  temperature of 68°C., and destroyed 
(in solution, though not in dry state) above 70°C., the necessary temperature varying 
inversely with the length of time of exposure.  The non-specific influence of adjacent 
ions and molecules on the thermodynamic environment, and the specific influence of 
many ions, especially metallic ones, has also frequently been evaluated.  Realization 
of the significance of oxidation-reduction systems is more recent, and while  the in- 
tracellular proteinases have been intensively investigated in this regard, the important 
extracellular proteinases and leucoprotease have been relatively neglected. 
Consideration  of the importance of oxidation-reduction systems began with  the 
discoveries  that HCN (Vines,  1903, 1905), H~S (Mendel  and Blood, 1910), cysteine, 
and HS glutathione (Grassman, yon Schoenebeck,  and Eibeler,  1931) increased  the 
activity of papain and of cathepsin (Grassman eta/., 1930; Waldsehmidt-Leitz, 1929). 
The physiological  significance of these findings was emphasized by the demonstration 
(Grassman, Dyckerhoff, and von Schoenebeck,  1930) that many intracellular pro- 
teases, both plant and animal, are accompanied by sulfhydryl compounds which serve 
as natural activators, presumably by virtue of their reducing action.  A theory for the 
mechanism of the  activation  of papain by reducing agents,  and of the  reversible 
inactivation of papain by careful use of oxidizing agents such as iodine or hydrogen 
peroxide (Bersin,  1933, 1934) was developed by Bersin (1935) and Hellerman (1937), 
who suggested that the disulfide form of the enzyme (En--S--S--En) is inactive, and 
that reduction of disulfide  groups to active sulfhydryl groups activates the enzyme: 
reduction 
En--S---S--En +  2H  + -t- 2(e)  '  oxidation .... 2En -  SH 
This sulfhydryl mechanism has been extended  by HeUerman (1937) and has been 
applied to many other enzymes.  Further  evidence for this mechanism is provided 
by the reversible inactivation of these enzymes (papain,  cathepsin, urease)  by mer- 
captide-forming reagents (such as benzyl mercuric chloride, p-tolyl mercuric chloride, 
cuprous oxide,  etc., represented below as Me) and their reactivation  by substances 
which decompose the mercaptides (Hellerman, 1939) : 
En--  SH-~ Me  +~-En-  S  --  Me-~-H  + 
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Objections to the sulfhydryl theory (Bergmann and Fruton, 1941), based on varying 
specificities of the activators unrelated to reducing potential, and on the mechanism 
of activation by HCN, will not be considered  at present.  It is desired  mainly to 
emphasize the significant r61e which biologically important thiol-sulfhydryl compounds 
(glutathione,  ergothionine,  cysteine,  cysteine  peptides,  sulfhydryl-containing pro- 
teins, etc.) and other oxidation-reduction compounds (e.g. ascorbic acid) play in the 
control of enzyme action.  For the sake of simplicity such control will be assumed to 
be exerted  by virtue  of  control  of  the  oxidation-reduction  system,  though  other 
mechanisms of action are not excluded. 
Table I attempts to summarize the literature on the importance of the oxidation- 
reduction system in the control of the activity of many enzymes.  First are listed the 
enzymes whose reduced form is more active than the oxidized form; then the enzymes 
whose oxidized form presumably is more active.  Activation and inhibition have in 
most cases been shown to be reversible and reciprocal,  particularly in that enzymes 
which  are activated by reducing agents  (especially  sulfhydryl compounds) are in- 
hibited by oxidizing agents (especiafly inhibitors of sulfhydryl groups). 
As previously mentioned,  the  study of the  influence  of the  oxidation-reduction 
system on extracellular proteinases and on leucoprotease has been relatively neglected. 
Grassman, Dyckerhoff, and  yon  Schoenebeck  (1930) demonstrated  that  cysteine, 
H2S, HCN, and pyrophosphate reduced the activity of trypsin, while cystine increased 
its activity, but they attributed these findings  to the inactivation of trypsin kinase 
by the reducing agents and activation by cystine, rather than to any direct effect on 
the enzyme.  Search of the literature revealed no report on the influence of the oxida- 
tion-reduction system on leucoprotease, or on the inhibitors of trypsin and leucopro- 
tease, including  serum antiprotease. 
Table II attempts to summarize the literature  on substances which,  in  suitable 
concentration, have been found to influence the activity of trypsin and leucoprotease. 
Because of  similarity of many properties,  leucoprotease and trypsin have been 
thought by some (Wfllstatter and Rohdewald, 1932) to be identical enzymes.  Others 
(Stern, 1931) have pointed to the difference in the effect of Mn++ and Fe++ (in suitable 
concentrations) on these enzymes and have concluded  that they are different.  Com- 
parison is difficult because crude trypsin, and leucoprotease as extracted from white 
blood ceils, are mixtures of enzymes, and furthermore the ]eucoproteases  of different 
animals may differ considerably in the kinds and amounts of enzymes present.  Thus 
the proteinase activity of the polymorphonudear leucocytes of carnivorous animals 
at pH 7 is said to be over twice as high as that of herbivorous animals (Wfllst;4tter 
and Rohdewald,  1932).  Barnes (1940) has compared the proteinases of rabbit and 
cat white blood ceils as foflows: 
P,  abt it  5at 
Lympho-I  Poly-  I  Lympho-I  Poly- 
cytes  ]  ~orphs  I  cytes  [  morphs 
Pmteinase active at pH 4 ("cathepsin") .......  [---~l--~l--~]  -4- 
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Parker and Franke (1917) also found no "tryptase" in rabbit polymorphs, but Weiss 
(1939) has reported the presence here of a  "tryptase" which digests casein or gelatin 
TABLE  I 
Protemases  activated by reducing  agents 
(a)  Papain proteinase  (79, 59, 35) 
(b)  Cathepsin  (35, 82) 
(c)  Ficin and bromelin proteinase  (41) 
(d)  Yeast proteinase  (33) 
(e)  Proteinases of anaerobic bacteria, and of aerobic bacteria in presence of Fe  ++ (85) 
Peptidases activated by reduclng agents 
(a)  Some yeast and mold dipeptidases (also activated by Zn  ++ or Mn  ++ (33) 
(b)  Some intestinal  dipeptidases  (also activated by Mn  ++ (31) 
(c)  Animal intracellular  ("catheptic") peptidases  (29) 
(d)  Bacterial  peptidases,  especially of anaerobic  bacteria  (also activated by  Zn  ++, Fe  ++, 
Pb  ++, Cu  ++, Mn  ++, Sn  ++, Cd  ++, Hg  ++) (9) 
(e)  Most d-aminopeptidases (11) 
Other enzyme systems activated by reducing agents 
(a)  Pneumococeal hemolysin (73) 
(b)  Lysozyme (60) 
(c)  Cerebrosidase (78) 
(d)  Muscle glycolysis (32) 
(e)  Urease (40) 
(f)  Serum complement (24) 
(g)  Stability of virus proteins (increased by reducing agents) (71, 3, 18, 61, 91) 
(h)  Liver pyruvate, malate,  and ketoglutarate  oxidase; adenosinetriphosphatase  (5) 
(i)  d-amino acid, l-glutamic acid, and monoamine oxidase; transaminase  (5) 
(j)  Yeast alcohol, liver choline, and bacterial  glycerol oxidase (5) 
(k)  Liver and bacterial  (E. toll) stearate,  bacterial oleate, heart ~-hydroxybutyrate oxidase; 
? pancreatic  lipase (5) 
(l)  Acetylcholine esterase;  ? serum mono-n-butyrin  and liver esterase (5) 
Proteinases inhibited by reducing agents 
(a)  Trypsin (kinase said to be inhibited)  (34) 
(b)  Proteinases of aerobic bacteria in absence of Fe  ++ (85) 
Peptidascs  inhibRed by  reducing agents 
(a)  Some yeast and mold dipeptidases  (also inhibited by Mn  ++ and polypeptidases  (33, 10) 
(b)  Intestinal leucine aminopeptidase  (33), effect counteracted by Mn  ++ and Mg  ++ (9) 
(c)  Papain peptidase  (12) 
Other  enzyme systems  inhibited by  reducing  agents 
(a) Protein synthesis  by papain (80,  not confirmed in 77) 
at pH 8.  Human polymorphs (obtained from the blood of myeloid leukemia patients) 
have been found to contain proteinase most active at pH 7 to 8, other proteinase most 
active at pH 4, and peptidase most active at pH 7 to 8 (Husfeldt,  1931). 
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TABLE II 
Substances which have been found to inhibit the activity of trypsin 
(a)  Serum and plasma  (44, repeatedly  confirmed) 
(b)  Charcoal (39) 
(¢)  Unsaturated fatty acids (49) 
(d) Tryptic digests of proteins (7, 47) 
(t)  Pancreatic trypsin inhibitor  (crystaUized--63) 
(f)  Serum trypsin inhibitor  (crystallized--72) 
(g)  Egg white antitrypsin (said to act by inhibiting  trypsin kinase--2) 
(h)  Cysteine,  HzS, HCN, and pyrophosphate  (said to act by inhibiting  trypsin kinase---34) 
(i)  Hydrogen ion concentration  other than the optimum of pH ffi 8 (37) 
(j)  Alcohol, formaldehyde,  thymol, chloroform, toluol,  some alkaloids,  t.g. hordenine  sul- 
fate (26) 
(k)  Glycerol (81) 
(l)  Triglycerides, sugar (concentrated),  asparagine, giutamic acid (27) 
(m) Glycylglycine, leucylgiycine, and slanylgiycine  (84) 
(n)  F-', CI- >  I- >  Br-; NH4  + >  K + >  Na  + (21) 
(o)  Cu++, Zn++ (76) 
(p)  Mn++ (89) 
(q)  Hg++  (25) 
(r)  Lecithin (75) 
(s)  Heparin (45) 
(t)  Quinine salts (55) (act by changing pH, according to 74) 
(u)  Urea salts  (74) 
(v)  Germanin  (Bayer 205) (8) 
(w)  Azodyes (56,  68) 
(#) Acridine  dyes  (trypailavin,  rivanol)  and  Congo  red  (6) 
(y) X-rays  and  ultraviolet  light  (19) 
(z) Bacteria  (53) 
Substsncee which have been found to increase the activity of trypsin 
(a)  Cystine (said toact by activating trypsin kinase--34) 
(b)  Asparagine, aspartic acid, ghitamic acid, cysteine, and CN- (accelerate the first stage of 
hydrolysis, according to 27) 
(c)  Fe  ++, Se  ++ (slightly) (89) 
(#)  Ca  ++, Mg  ++ (22) 
(e)  Ag  + (76) 
(f)  Primary phosphate (28) 
Substances which Imve been found  to inhibit  the activity  of  leucoprotease 
(a)  Serum and plasma (65, repeatedly  confirmed) 
(b)  Tryptic digests of proteins  (according to 69) 
(c)  Unsaturated fatty acids (50) 
(d)  Hydrogen ion concentration  other than the optimum of pH =  7 (76) 
(e)  Fe  ++ (89) 
(I3  Quinine salts (55) (act by changing pH according to 74) 
(g)  Phosphatide  of tubercle bacillus (70) 
Substances which have been found to increase the activity of leucoprotease 
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reference to serum antiprotease.  Mammalian and bird serum and plasma have long 
been known to strongly inhibit many animal and plant proteases, including those of 
pancrease  (trypsin),  yeast,  leucocytes  (leucoprotease),  and  tissue  cells  (cathepsin) 
(Jochman, 1908).  Also present in the serum are small amounts of protcases active at 
neutral pH and in acid medium (Opie and Barker,  1908),  but these are neutralized 
by a considerable excess of serum antiprotease.  The nature, and the reasons for the 
physiological and pathological variation of the antiproteolytic activity of the serum 
have been the subject of much dispute.  Evidence has been presented  (Grob, 1943) 
that products of protein hydrolysis (probably one or more polypeptides)  formed in 
the intestine and parenterally are an important factor contributing to this activity of 
the serum.  Elucidation of the mode of action of the antiproteolytic activity of the 
serum would  throw considerable  light on conditions affecting the activity of such 
important proteolytie enzymes as leucoprotease and trypsin. 
C. THE CONTROL  OF THE ACTIVITY OF  TRYPSIN, LEUCOPROTEASE, AND 
S~RO~ ANTIPgO~EASE (EX~ERI~NTAL DATA) 
1. Determination  of Proteolytic Activity 
Proteolyfic and antiproteolytic activity were determined by following the digestion 
of  casein  nephelometrically  by  modification  of  the  method  of  Wunderly  (1936). 
Digest mixtures were prepared by adding the following reagents in the order given: 
(a)  0 to 2 cc. of the solution to be tested for influence on protease action, 
(b)  3.5 cc. of M/15 KH~PO4  -  K2HPO4 buffer (pH 7.5), 
(c)  0 to 2 cc. of 0.85 per cent NaCl, 
(d)  1 cc. of enzyme solution, 
(e)  3.5 cc. of 0.5 per cent casein solution in 0.006 N NaOH (pH 10.4), 
00  5 drops of toluol (did not influence digestion, and prevented bacterial growth if 
tubes were stoppered). 
The total volume of each digest mixture was 10 cc.  Ten minutes were allowed to 
elapse  between  the addition of the enzyme and  the casein solution,  thus allowing 
exposure of enzyme to inhibitor for an appreciable time interval before addition of 
substrate.  Immediately after the addition of the substrate and mixing, 2 cc. of the 
mixture were removed for determination  of pH (by Beckman glass electrode), and 
another 2 cc. were removed, added to 2 cc. of 25 per cent HC1 and 1 cc. of 20 per cent 
sulfosalicylic acid, and the turbidity of the resulting suspension of undigested casein 
determined with the aid of a photoelectric nephelometer.  Similar determinations of 
the concentration of undigested casein were again made after an interval of digestion 
at 37°C.  Calibration of the nephelometer, i.e. translation of turbidity measurements 
into corresponding concentrations of casein, was possible, since known concentrations 
of casein were found to transmit light in accordance with I~mbert-Beer's law,  the 
concentration of turbid particles being proportional to the logarithm of the per cent 
of incident monochromatic light transmitted.  A green filter which transmitted light 
of  540  miUimicrons wave length  gave  the greatest  range  of scale  readings.  The 
logarithm of the per cent of incident monochromatic light absorbed (R) was trans- 
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(F  =  C/R).  Concentrations of solution (a) in the digest mixture which caused the 
pH to vary outside of the range 7.4 to 7.9 are not included in the tables.  The pH 
of the digest mixture in the absence of solution (a) was 7.8. 
The concentration of crude trypsin in the digest mixture was 0.01 mg./cc., of crude 
papain (partly activated by dissolving in water containing a few milligrams of cysteine 
which was then removed by dialysis)  0.1  mg./cc., and of crystalline trypsin 0.005 
mg./cc.  The concentration of leucoprotease (cat) thaLwas used produced approxi- 
mately the same degree of casein proteolysis in 17 hours as was produced in 7 hours by 
0.01 mg./cc, of crude trypsin, in 17 hours by 0.1 mg./cc, of crude papain when fully 
activated, and in 1 hour by 0.005 mg./cc, of crystalline trypsin.  (These were the 
digestion times, at 37°C., used throughout the experiment.) 
The initial concentration of casein in each digest mixture was 1.75 mg./cc.  The 
concentration of casein after partial digestion was determined nephelometrically, as 
described above.  Subtraction disclosed the concentration of casein that was digested 
by the enzyme.  This enabled  calculation of the concentration of free,  i.e. active, 
enzyme with  the  aid of Schutz's "law": 
X K~/T (at constant incubation  time) 
where X  =  concentration of protein digested, 
T  --  concentration of free  (i.e.  active) enzyme, 
K  -- a constant which is determined by digesting casein with known concentrations 
of each enzyme for the time intervalS used experimentally, (e.g. 0.01 mg./cc, of crude 
trypsin digested 0.305 mg./cc, of casein in the standard time of 7 hours so that K  = 
3.06  for these  conditions). 
Since the initial concentration of protease (E) in each case was 0.01 mg./cc, of crude 
trypsin, 0.005 mg./cc, of crystalline trypsin, 0.1 mg./cc, of papain, and an equivalent 
in leucoprotease activity, the per cent of F. that was free (i.e. active) in the presence 
T 
of solution (a) is equal (for crude trypsin) to ~-~ X  100 per cent ffi T  X  104 per cent, 
T 
for crystalline  trypsin ~-~  ×  100 per cent --  2 X  T  X  104 per cent, and for papain 
T 
×  100 per cent =  T  ×  108 per cent.  T  was calculated  for each  digest  mixture 
0.1 
(and expressed in equivalent weight of trypsin in the case of leucoprotease), and the 
results are recorded in the tables as "the per cent of enzyme activity." 
Wherever serum or plasma was used in these experiments the source was human. 
2. Preparation oJ Leucoprotease 
The proteolytic enzymes that were studied by this method were crude  trypsin 
(Fairchild,  beef),  crystalline trypsin, lyo-leucoprotease, desmo-leucoprotease, 
and crude papain.  SuFficient crystalline trypsin was available for only part of 
the experiments.  Results obtained with desmo-leucoprotease were essentialy 
the same as those obtained with lyo-leucoprotease, so that only the latter are 
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Polymorphonuclear leucocytes were obtained from rabbits and from cats by inject- 
ing 10 cc. of 5 per cent aleuronat and 5 per cent tragaeanth into each pleural and 
peritonea] cavity of 8 animals (4 of each species), killing the animals after 24 hours by 
bleeding from the carotid artery, collecting the exudates in isotonic saline plus citrate, 
centrifuging,  and  washing  the  sedimented  leucocytes  several  times with isotonic 
sodium chloride to thoroughly remove the supernatant fluid, which has been found 
(Opie, 1905, 1905) to be high in antiproteolytic activity.  Smears of the sediment 
showed over 90 per cent polymorphonuclear leucocytes, the remainder being mononu- 
clears and red blood cells.  Leucoprotease may be obtained from the sediment by 
allowing the cells to autolyze, or by extraction with glycerol.  The method of extrac- 
tion was used, the sediment being shaken for several hours in 100 per cent glycerol 
and  then  centrifuged.  The  supematant  contains  the  lyo-leucoprotease  ("free" 
leucoprotease) of Wiltst~tterand Rohdewald (1932).  The resulting sediment was then 
extracted with 60 per cent glycerol and centrifuged, the supernatant now containing 
the  desmo-leucoprotease  ("bound" leucoprotease). 
Both the lyo and desmo preparations from rabbit leucocytes failed to show 
appreciable protease activity (on casein substrate at pH 7.8).  This is con- 
firmatory of the findings of Parker and Franke  (1917)  and Barnes  (1940), 
who used other methods of preparation.  Preparations from cat leucocytes 
were high in protease action at neutral pH, and are discussed below.  It is 
interesting in this respect to note that skin and subcutaneous abscesses  (as 
produced by injection of staphylococci) were found to be grossly different in 
rabbits and in cats.  In cats (as in man) resolution, or liquefaction, of such 
abscesses commonly took place, presumably because of proteolysis by leuco- 
protease.  In rabbits such liquefaction was found to be much slower and less 
marked, with the result that the abscess contents had a caseous, or "cheesy," 
appearance.  It is suggested that this difference is due to  the absence  from 
rabbit polymorphonuclear leucocytes, and the presence in cat (and  human) 
polymorphs, of protease active at neutral pH. 
3. Substances Which Inhibited Leucoprolease and Trypsin 
(a) Reducing Agents.--Cysteine,  sodium thioglycollate, H--S  glutathione, 
ascorbic acid, sodium cyanide, and hydrogen sulfide, (in concentrations indi- 
cated in Table III), were found to be strongly inhibitory of leucoprotease and 
trypsin.  These reducing compounds (with  the exception of ascorbic acid) 
considerably increased the activity of partly activated papain, showing the 
contrast  in  the  influence  of  the  oxidation-reduction  system  on  these 
proteases. 
The reducing capacity of each digest mixture was determined by its ability 
to decolorize a  0.0005  x~ solution of sodium-2,6-dichlorophenol indophenol. 
Charts 1 and 2 show that for each reducing agent the degree of inhibition of 
leucoprotease and trypsin, and the degree of activation of papain, are propor- DAVID  GROB  227 
tional to the reducing capacity of the medium.  The results also indicate that 
there is no relation between the reducing capacity of different reductants and 
TABLE III 
The Influence of Reducing Agents on the Activity of Leucoprotease,  Trypsin, and Papain 
(The per cent of enzyme activity is recorded.  The reducing capacity is recorded as the 
cubic centimeters of 0.0005  ~s  Na-2,6-dichlorophenol  indophenol decolorized by  1 cc. of 
digest mixture.) 
Compound  Concentration in 
digest mixture 
geduclng !  ] 
capacity of Leucopro-  Crude Ct~ilinne 
digest  tease  trypsin  •  Papain 
mixture 
em./lO0 c¢. 
None (control) ........  I  ~  0  100  100  100  3 
Cysteine .....  0.10  5.5  0  44  41  100 
,,  0.05  2.9  32  70 
,,  0.04  2.5  38  79  77 
"  0.02  1.3  60  90 
"  0.01  0.5  ,  72  100  47 
,,  0.005  0.1  79 
Sodium thioglycollate.  0.60  1.2  76 
,,  "  0.40  0.75  90  66 
,,  "  .....  0.10  0.25  95 
.'  0.04  0.10  106  100 
Glutsthione.. 
C~ 
~rbic  add. 
Ascorbic add q-  Fe  ++ .... 
NaCN. 
c~ 
0.14  0.5  53  79 
0.035  0.3  72  88 
0.014  0.1  105  96 
0.10  9.5  31  89 
0.05  4.8  44  92 
0.10 -b 0.01 Fe  ++  9.0  1  52 
0.05 q- 0.005 Fe  ++  4.5  17  70 
0.02 "4- 0.002 Fe  ++  0.5  62  90 
0.25  0  8  28 
0.125  0  14  55 
1/5 saturated  18  60 
1/50 saturated  87  106 
74  100 
82 
83  98 
75 
2 
7O  0 
0 
42  13 
0 
0 
50  106 
98 
93  28 
13 
their effect on the enzymes.  This is no doubt  due in part to differences in the 
reducing  potential  of  each  reductant.  For  instance,  ascorbic  acid, half  re- 
duced,  has an E0 of +0.06  volt at  pH  7, while cysteine  has  an E0 of  --0.3 
volt, so that it is not surprising  that ascorbic acid has less effect on the enzymes Ii0' 
i00, 
90' 
80, 
70- 
60- 
50 o 
40- 
30 = 
20- 
10- 
0 
O~ti~w~  8  ~ ~  °  ~  ~  "  t 
>< 
~e 
M Trypsin 
--4Leucoprotease 
.......  ~ Papain 
t = Thloglycollate 
c = Cysteinc 
II01  • 
i00- ~ 
90-  -"- 
70-  J 
50- 
'~  30-  a  +  Fe  ++ 
o 
(z, 
I0- 
Reducing capacity of medium 
C~T  1.  The influence of reducing agents (cysteine and sodium thioglycollate) on 
the activity of leucoprotease, crude trypsin, and papain.  (The reducing capacity of 
the medium is recorded as the cubic centimeters of 0.0005 ~  Na-2,6-dichlorophenol 
indophenol decolorized by 1 cc. of digest mixture.) 
It  ~  Tryps  in 
~---  --  ---e  Leucoprot  ease 
+-  ........  $  Papain 
g = Olutathione 
a = Ascorbic acid 
O,,.~ 
o  ~  ..........................  _+.+__.___._L--~  ......  ,,  .......  _-'c-_ _,_ _--=-~_  _  _L  _  _. 
-I-,  I  '  I  '  I  '  l  '  I  I 
i  2  ,3  4  5  6  7  8  9  9.5 
Reducing capacity of medium 
Ct[ART 2.  The influence of reducing agents (glutathione, ascorbic acid, and ascorbic 
acid  +  Fe++) on  the  activity of leucoprotease, crude  trypsin, and papain.  (The 
reducing capacity of the medium is recorded as the  cubic centimeters of 0.0005 xt 
Na-2,6-dichlorophenol indophenol  decolorized  by 1 cc. of digest mixture.) 
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than cysteine even when the reducing capacity of the former is higher.  How- 
ever, that other mechanisms may also be involved is suggested by the finding 
that the addition of a  few milligrams of ferrous salt increased the inhibition 
of leucoprotease and trypsin by ascorbic acid (in the case of trypsin consider- 
ably in excess of the additive effect (see Table V)), and caused papain to be 
slightly activated by ascorbic acid, without changing the reducing capacity 
of the medium.  A possible  mechanism for the greater inhibition of trypsin 
and the beginning activation of papain is suggested by the observation (Parr, 
1935) that the ferrous-ascorbic acid complex is a much more potent reducer of 
disulfide to thiol groups than ascorbic acid alone.  Any inactive disulfide com- 
pounds in the mixture would thereby  be converted into potent thiol compounds. 
The contention of Grassman,  Dyckerhoff, and von Schoenebeck (1930), 
that cysteine, H~S, HCN, and pyrophosphate retard tryptic activity because 
they inhibit trypsin kinase is disproved by demonstration of the inhibition of 
crystalline trypsin and of leucoprotease, both of which exist in the activated 
state and require no kinase for their action.  (Willst~tter and Rohdewald, 1932, 
demonstrated that leucoprotease does not require kinase.) 
The physiological significance of this inhibition of trypsin and leucoprotease 
is made evident by recalling  that these enzymes probably never act  in  the 
body without the presence of appreciable concentrations of biologically  im- 
portant  thiol-sulfhydryl reductants (glutathione, ergothionine, cysteine, cys- 
teine peptides, sulfhydryl-containing proteins), as well as ascorbic acid.  The 
thiol-sulfhydryl compounds were known to activate the intracellular cathep- 
sins (just as they activate papain) but their significance as inhibitors of trypsin 
and  leucoprotease  has  not  been  appreciated.  Similarly ascorbic  acid  has 
been known to activate cathepsin and to inhibit papain (except in the presence 
of  sufficient  ferrous  ions  (Maschmann  and  Hehnert,  1934) and  disulfide- 
thiol compounds (Parr, 1935)), but its inhibition of trypsin and leucoprotease 
has not previously been evaluated. 
(b) p-Arainobenzoic Acid, Sulfonamides, and Diphenyl Sulfones.--Evidence 
has been presented (Grob, 1943) that the growth of bacteria in the body will 
be more rapid, and the inhibition of sulfathiazole will be greater, when con- 
siderable protease is present and when the fluid inflammatory exudate is small 
and poor in antiprotease.  Protease is believed to exert this effect because the 
products of proteolysis both accelerate bacterial growth (especially when the 
medium is  poor  in  non-protein nitrogen)  and  inhibit  sulfonamide action. 
Because of this physiological significance of protease, the influence on leucopro- 
tease of the sulfonamides and related compounds was studied.  Results are 
recorded in Table IV.  They show that p-aminobenzoic acid and the sulfon- 
amides tested (especially sulfathiazole) inhibited leucoprotease in physiological 
concentrations.  Promin and a  number of other diphenyl sulfones  (kindly 
provided by Dr. Eleanor Bliss)  were similarly tested, in  an effort to find a 230  PROTEOLYTIC  ENZI'~[ES.  I 
compound of greater inhibitory power that might be used to inhibit  leucopro- 
tease when desired, for instance in assisting the action of sulfonamides in puru- 
lent lesions.  The sulfones that were tested inhibited  leucoprotease no  more 
than  the sulfonamides,  and except for promin,  the sulfoxalate  condensation 
TABLE IV 
The Influence of p-Aminobenzoic Acid, Sulfonamides, and Diphenyl Sulfones on Leucoprotease 
and Trypsin 
(The per cent of enzyme activity is recorded.) 
Substance  Concentration in  digest mixture  Leucoprotease Crude  trypsin 
Control ............................... 
p-Aminobenzoic acid .................... 
t¢  ¢c 
L¢  t~ 
Sultathia~ole ........................... 
c| 
~L 
Sulfanilamide ........................... 
L¢ 
~1 
Sulfadiazine. 
~L 
Lt 
C¢ 
Sulfaguanidine ........................ 
L¢ 
tl 
~.HOO c~. 
0.040 
0.010 
0.004 
0.~ 
0.~0 
0.010 
0.~ 
0.040 
0.020 
0.010 
0.004 
0.040 
0.020 
0.010 
0.004 
0.040 
0.020 
0.010 
0.004 
100 
20 
90 
107 
10 
17 
25 
33 
18 
21 
37 
59 
25 
40 
60 
87 
4 
9 
22 
54 
100 
97 
104 
110 
90 
100 
product  of diphenyl  sulfone,  p,p'-diglucosaminodiphenyl  sulfone,  and p,p'- 
diaminodiphenyl sulfone salicylate, they have the disadvantage of being much 
less soluble. 
The compounds that were tested inhibited  (crude) trypsin slightly or not at 
all, so that values obtained for trypsin are for the most part omitted.  It may 
be that smaller  concentrations of trypsin would have been inhibited.  (The 
initial concentration of trypsin in the digest mixtures was greater than that of DAVID GROB  231 
leucoprotease,  since  leucoprotease  digests  were  incubated  longer  than  the 
tryptic digests in order to reach the same extent of casein digestion.) 
(c) Heavy Metals.--Aluminum,  manganous, ferrous, mercuric, zinc, and cu- 
pric salts, in the  concentrations  shown,  inhibited leucoprotease and  trypsin 
TABLE IV--C~nd~/~ 
Substance  Concentration in  digest mixture  Leucoprotca~ 
Promin ................................ 
ct 
Diphenyl sulfon¢~ 
p, p'-Diaminodiphenyl  ................... 
p, f-Diaeetylamino  ..................... 
p, p'-Diformylamino  ..................... 
p , p'-Dipropionylamino  .................. 
p,p'-Dibutyrylamino  ................... 
p-Acetoamino f-amino ................... 
p-Sulfoxalate  ........................... 
p-Benzylideneamino f-amino ............ 
2,4-Dinitro 4'-amino  .................... 
N 1 Benzol p, p'-diamino  ................. 
p-Propionylamino  f-amino .............. 
p-Butyryl f-amino ..................... 
p-Acetylsmino f-hydroxy  ............... 
Disulfonamido  .......................... 
Diphenyl sulfone ....................... 
p-Cinnamalamino f-amino .............. 
p-(N-p-tolylglycyl)amino f-amino  ........ 
p, p'-Diglueosamino  ..................... 
p, p'-Diaminodiphenyl  sulfone salicylate... 
p, p'-Diethanolamino  .................... 
2,4-Dinitro 4'-acetoamino  .............. 
p-Monoacetylamino ................... 
gm.llO0~. 
0.025 
0.012 
0.002 
0.020 
tc 
C¢ 
c~ 
c~ 
cc 
c¢ 
~C 
cC 
Ct 
cC 
t~ 
tt 
74 
84 
101 
87 
76 
72 
65 
72 
56 
68 
65 
76 
84 
78 
92 
68 
76 
84 
74 
81 
74 
80 
84 
74 
56 
(Table V).  Manganous and ferrous salts had a much greater inhibitory effect 
on leucoprotease than  on  trypsin. 
(d) Other Inkibitors.--Other  substances which were found to inhibit leuco- 
protease (and usually trypsin) are listed in Table VI.  These include serum 
and plasma (which are equally active in the inhibition of leucoprotease and 
trypsin and are among the most potent inhibitors of these enzymes), thiourea, 
heparin, glutamic acid, tyrothricin, ammonium salts, calcium chloride, aspara- 
gine, bile salts and acids, and (to a lesser degree) organic mercury compounds. 
(e) Polypeptide Trypsin Inhibitors.--Polypeptide  inhibitors of trypsin can be 232  PROTEOLYTIC  ENZYMES.  I 
prepared in concentrated form from a  tryptic digest  of casein  (Hussey and 
Northrop, 1923).  Such a concentrate was prepared, and similar concentrates 
were made from tryptic digests of egg albumen and serum albumin.  A trypsin 
inhibitor preparation was also extracted (by the method of Balls and Swenson, 
1934) from the thin fraction of egg white, which is believed to be a  proteolytic 
product of the more viscid fraction of egg white.  These preparations  were 
found to inhibit trypsin to a  much greater degree than leucoprotease (Table 
TABLE V 
The Influence of Hea~y MeLals on the Activily of Leucoprotease  and Trypsin 
(The per cent of enzyme activity is recorded.) 
Substance  Concentration in  digest mixture  Leucoprotease  Crude trypsin 
None (control) ....................... 
A]¢"l 
gr~./100 co. 
2.0 
0.05 
0.02 
0.01 
100 
9 
12 
40 
103 
Mn(Ac),. 4H,O ...................... 
~c 
FeSO,  .............................. 
HgC1,  .............................. 
ZnCI2  .............................. 
CuSO, ............................. 
0.20 
0.04 
0.10 
0.02 
0.30 
0.04 
Suspension 
0.05  66 
0.05  16 
100 
20 
77 
28 
104 
66 
97 
50 
48 
VII), a finding which lends support to the belief that although leucoprotease 
and trypsin are very similar, they are probably not identical enzymes. 
An interesting observation was that the boiling of solutions of tryptic digests 
of proteins increased their power of retarding the activity of trypsin.  This 
is in contrast to serum, which loses its antitryptic and antileucoprotease ac- 
tivity when heated at 80°C. for 10 minutes.  These findings will be discussed 
later, under consideration of the nature of serum antiprotease. 
Egg white antitrypsin inhibited crystalline as well as crude trypsin.  This 
disproves the theory of Balls and Swenson (1934) that egg white antitrypsin DA¥IDGROB  233 
acts by inhibiting trypsin kinase, since crystalline trypsin requires no kinase 
for its  action. 
TABLE VI 
The Influence of Some Other Substances on the Activity of Leucoprotease and Trypsin 
(The per cent of enzyme activity is recorded.) 
Substance 
None (control) ..................... 
Serun~  ............................. 
Serum heated at 80 ° for 10 rain  ....... 
Plasma ............................ 
Plasma heated at 80  ° for 10 rain  ...... 
Urea  ............................... 
c~ 
cc 
Thiourea .......................... 
~c 
cC 
Heparin ........................... 
ct 
Glutamic acid ...................... 
Quinine mono-HC1 .................. 
cc  c~ 
Penicillin  ......................... 
Cc 
Concentration in  Leucopro-  Crude 
digest mixture  tease  trypsin 
Oa./!O0 co. 
100  100 
Tyrothricin  ........................ 
~C 
NH~H~PO~ ......................... 
Cc 
(NH,hSO~  ......................... 
NH~Os .......................... 
cc 
Nt-I4 citrate ........................ 
cC  C~ 
oxalate ........................ 
cc  cc 
Nt~ tartrate ....................... 
~  Cc 
0.5~r  cent 
0.5 per cent 
0.5 per cent 
0.5 p~cent 
2.0 
0.5 
0.2 
1.0 
0.25 
0.10 
0.06 
0.015 
0.006 
0.20 
0.02 
0.20 
0.02 
500uni~/100~. 
50uni~/100cc. 
0.008 
0.0008 
0.20 
0.05 
0.02 
0.005 
0.05 
0.01 
0.05 
0.01 
0.10 
0.02 
0.10 
0.02 
0.10 
0.02 
3 
105 
3 
103 
81 
89 
87 
45 
58 
72 
72 
8O 
100 
20 
54 
46 
63 
78 
73 
14 
18 
4 
68 
74 
82 
82 
94 
72 
89 
39 
74 
72 
100 
68 
93 
3 
112 
3 
110 
105 
98 
108 
112 
106 
94 
90 
95 
98 
30 
100 
19 
91 
104 
91 
7O 
94 
7O 
84 
104 
95 
95 
94 
74 
82 
75 
99 
100 
101 
92 
94 
c~e 
100 
6 
108 
7 
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TABLE VI--Conclnded 
Substance 
CaCh. 
¢~ 
Na2S04 
Asparagine... 
c~ 
Na glycocholate.. 
Na taurocholate.. 
Cholic acid... 
Desoxycholic acid ...... 
Boiled crude trypsin. 
Benzyl ttgC1 .... 
p-tolyl HgC1. 
Fig di-p-Tolyl 
Concentration in 
digest mixture 
gm./lO0  co. 
0.05 
0.02 
0.20 
0.40 
0.04 
0.10 
0.02 
0.10 
0.02 
0.10 
0.02 
0.50 
0.05 
0.004 
1/50 saturation 
~c  ~c 
~c  c~ 
Leucopro- 
tease 
53 
88 
68 
6 
15 
8 
21 
52 
82 
0 
11 
6 
11 
75 
66 
82 
84 
Crude 
trypsin 
64 
89 
104 
98 
104 
49 
104 
98 
102 
85 
105 
104 
108 
90 
80 
75 
92 
Crystalline 
trypsin 
100 
90 
102 
TABLE VII 
The Influence of Prepared Trypsin Inhibitors on the Activity of Leueoprotea~e and Trypsin 
(The per cent of enzyme activity is recorded.) 
Substance 
None (control) 
Egg white antitrypsin ..... 
Boiled egg white antitrypsin. 
Tryptic digest of egg albumen .... 
Boiled tryptic digest of egg albumen... 
Tryptic digest of serum albumin ...... 
Boiled tryptic digest of serum albumin 
Tryptic digest of casein ........ 
Boiled tryptic digest of casein. 
Concentration 
in digest 
mixture 
gm./lO0  cc. 
0.2 
0.0.5 
0.2 
0.2 
0.2 
0.2 
0.2 
0.2 
0.2 
Leucopro- 
tease 
100 
100 
101 
101 
100 
98 
91 
95 
98 
93 
Crude 
trypsin 
100 
17 
35 
17 
67 
37 
84 
73 
86 
47 
Crystalline 
trypsin 
100 
35 
84 
86 
35 
4. Substances Which A ccderated Leucoprotease and Trypsin 
A  number  of  oxidizing  agents  were  found,  in  suitable  concentration,  to 
increase the activity of leuCoprotease and trypsin  (Table VIII).  This was in 
direct  contrast  to  their  inhibiting  effect  on  papain.  Whether  the  oxidants DAVID GROB  235 
exerted their effect directly on the leucoprotease and trypsin, or by oxidizing 
unknown reductant inhibitors present in the digest mixtures, was not ascer- 
tained.  Higher  concentrations,  especially  of  stronger  oxidizing  agents, in- 
hibited and could even completely prevent the action of these two proteases. 
TABLE VIII 
Tke Influence of Oxidizing  Agents on the Activity of Leucoprotease and Trypsin 
(The per cent of enzyme activity is recorded.) 
substance 
None (control).. 
~-Cystine  ..... 
cc 
Isin KI. 
ICl, tri-, 
cg 
[Br .... 
H~O~ 
Dakin's solution. 
Dichloramine T. 
Azochloramide  ...... 
NaC1Os. 
c~ 
NaBrO8 
cc 
Na per C1Os. 
~c  cc  ~ 
Cu20 (suspension) 
c~  c~ 
Ferricyanide. 
cc 
p-Iodosobenzoic acid 
~c  c~ 
Concentration  in  Leucopro-  Crude  Crystalline 
digest mixture  tease  trypsin  trY1~in 
m  100  100  100 
0.02  107  120  110 
0.01  106  112 
0.004  103  105 
0.004 (each)  145  77  83 
0.01  40  20  41 
0.001  115  106 
0.02  0  0  0 
0.001  110  105  100 
3 parts in 100  106  108  103 
1 part in 1,000  107  107  104 
0.015  105  110  105 
0.06  121  114  110 
0.40  108  102 
0.04  123  115  106 
0.40  30  85 
0.04  105  110  105 
0.40  20  105 
0.04  110  115  107 
0.40  92  104 
0.04  104  110  98 
0.20  70  85 
0.02  106  104  100 
0.20  82  116 
0.02  109  118 
CO. 
The increase of leucoprotease and tryptic activity in the presence of mild 
oxidizing agents corresponds with the finding of their inhibition by reducing 
agents,  and supports the contention that the  oxidation-reduction system is 
important in the control of the activity of these proteolytic enzymes. 
That the oxidation-reduction system may be important in protein synthesis 
too is suggested by a report (Voegtlin et at., 1932) that oxygenation favors the 
synthesis of protein by papain from protein digests and tissue extracts.  Others 236  pROTEOLYTIC  ENZYM3ES.  I 
(Strain  and Linderstr~m-Lang,  1938)  have failed to reproduce this finding, 
but in view of the fact that proteolytic enzymes have been found by Wasteneys 
and Borsook (1930)  to synthesize proteins from split products (by means of 
equilibrium systems which could continuously remove the synthetic product), 
it is very possible that  the oxidation-reduction  system will  be found to be 
significant in protein synthesis, as it is in proteolysis. 
5. Substances Which Inhibited the Antiproteolytic Activity of the Serum 
The cause of the antiproteolytic activity of the serum has been the subject 
of much dispute.  This activity has been attributed to antibodies to trypsin 
and/or leucoprotease (Jochman, 1908), to adsorption of the enzyme by serum 
albumin (Hedin, 1907), to unsaturated fatty acids (Jobling and Petersen, 1914), 
and to products of protein digestion, probably polypeptide in nature, and prob- 
ably produced both in the intestine and parenterally (Grob, 1943). 
(a) Inhibitors of the Antiproteolytic Activity of the Serum.--In Table IX are 
listed the substances which, in suitable concentration, were found to inhibif 
the antiproteolytic activity of the serum.  These are seen to be, for the most 
part,  oxidizing  agents.  (Dakin's solution was especially effective, which is 
interesting in view of its ability to accelerate the solution of pus.)  An effort 
was made to use concentrations of oxidant which decreased rather than  in- 
creased the activity of the proteases, so as to differentiate between the direct 
effect on the enzymes and the effect on the antiproteolytic activity of the serum. 
In addition to the oxidants,  three other substances of special interest:  zinc 
chloride, copper sulfate, and o-iodosobenzoic acid, inhibited the antiproteolytic 
activity of the serum.  These substances are special inhibitors of sulfhydryl 
groups (Hellerman et al.,  1941). 
(b) The Nature of the Antiproteolytic Substance in the Ser,im.--Evidence has 
been presented that:  (1) Leucoprotease and trypsin are readily inhibited by 
reducing  agents,  including  thiol-sulfhydryl  compounds  and  ascorbic  acid; 
(2)  the antiproteolytic activity of the serum is inhibited by oxidizing  agents 
and by some special inhibitors of sulfhydryl groups; and (3) the antiproteolytic 
activity of the serum is due in part to protein degradation products  (Grob, 
1943) which are most likely polypeptides. 
On the basis of this evidence it is suggested that the antiproteolytic activity 
of the serum is at least partly due to reducing agents in the serum, including 
polypeptides (particularly  those containing  thiol-sulfhydryl compounds such 
as cysteine) and  to a  lesser degree ascorbic acid.  That  the part played by 
ascorbic acid in this activity is a minor one is indicated by the evidence that 
the  antiproteolytic activity of the serum  (as tested  against  trypsin)  differs 
from ascorbic acid in several respects.  The antiproteolytic activity is largely 
confined to the albumin fraction of the serum  (Landsteiner,  1900); it is not 
dialyzable (Fujimoto, 1918); it is not freely diffusible in the body except when DAVID GROB  237 
inflammation  or  other  pathologic  process  increases  capillary  permeability 
(Weinberg and Laroche,  1909); and it could be accounted for to only a  small 
extent by the concentration of ascorbic acid in the serum, which is 1 to 2 mg. 
per cent when the body is saturated with it.  Serum polypeptides, on the other 
hand, would behave like serum antiprotease if the evidence advanced by Loise- 
TABLE IX 
Tke Influence of Oxidiving Agents and Some Special Sulfhydryl Inkibitors on tke Antiproteolyt~ 
Activity of the Serum 
(The per cent of enzyme activity is recorded.) 
Substance 
None (control)  . 
Serum heated at 80  ° for 10 rain  .... 
Carboxypeptidase  (incubated with 
Leucopro-  Cryd.e 
Concentration in  Leueor  to-  tease  t~oPS~n  digest mixture  teas :  +0.5  Crut e  per cent  tryp~  [n  per cent 
8erunl  serunl 
gm./lO0 cc. 
100  3  100  3 
0.5 percent  105  112 
serum for 24 hrs.). 
IC1, tri. 
~C 
IBr 
IC1, mono. 
I~ in KI ...... 
H~O2. 
Dakin's solution. 
Azochloramide ..... 
Chloramine T. 
Dichloramine T. 
NaCI08.. 
NaBr08 
Na per C108. 
Cu20. 
o-Iodosobenzoic acid. 
~c  ct 
ZnC12 (suspension) 
CuSO~. 
Few milligrams  105  23  96  25 
. [  0.001  115  20  106  18 
0.0005  98  148  99  30 
O.OO1  110  26  105  8 
0.001  101  18  70  6 
0.004 each  145  65  77  9 
3 parts in 100  106  40  108  14 
3 parts in 1,000  76  67  75  42 
0.006  99  16  97  8 
0.02  92  2  94  14 
0.015  105  23  110  15 
0.40  108  20  102  6 
O. 40  70  30  85  9 
0.40  115  20  105  8 
0.40  92  15  104  6 
0.20  82  4  116  10 
0.02  109  4  118  9 
0.05  66  18  50  8 
0.05  16  9  48  7 
leur and Colliard (1937)  that these polypeptides are normally adsorbed to the 
serum  proteins  is  confirmed,  for  they  would  then  be  fractionated  with the 
proteins;  they would not  be freely dialyzable; and  they would not be freely 
diffusible in the body except when capillary permeability is increased. 
(c) The Nature of Other Trypsin Inhibitors.--]~eference  was previously made 
to a  number of polypeptide trypsin inhibitors which have been prepared from 
tryptic digests of proteins, and from the thin fraction of egg white.  The latter, 238  PROTEOLYTIC  ENZYMES.  I 
egg white antitrypsin, has been studied analytically (Balls and Swenson, 1934) 
and has been found to be a  polypeptide rich in cysteine and in thiol groups. 
It may well owe its antitryptic activity to the presence of active sulfhydryl 
groups.  The crystalline trypsin inhibitors of pancreas (Northrop and Kunitz, 
1932) and serum (Schmitz, 1938) have probably also been studied analytically, 
but any such data were not readily available. 
The increase in  the activity of trypsin inhibitor solutions  (prepared from 
protein digests)  as a  result of boiling is demonstrated in Table VII.  It has 
been shown  (Dubos,  1929)  that  boiling solutions  of peptone increases  their 
reducing capacity.  This would  be  expected  to  increase  the  antiproteolytic 
activity, if such activity were due to reducing substances.  The destruction of 
TABLE X 
Substances Wkick Were Found to Have No Effect on the Antiproteolyti¢ Activity of the Serum 
(Otker Tkan an Additive Effect on the Enzyme Used in Testing) 
Substance  Concentration 
Na iodate ................................................ 
Ferricyanide... 
¢¢ 
l-Cystine  ................................................. 
p-Tolyl HgC1  ............................................. 
Benzyl HgCI  .............................................. 
Hg di-p-tolyl  ............................................. 
Sodium selenite  .......................................... 
Cysteine  ................................................ 
Ascorbic acid ............................................ 
Na oxalate .............................................. 
Na citrate ............................................... 
Sulfathiazole  ............................................. 
0.25 
0.20 
0.05 
0.01 
1/50 saturation 
1/50 saturation 
1/50 saturation 
0.05 
0.05 
0.05 
0.05 
0.05 
0.012 
the antiproteolytic activity of the serum by heat (80°C. for 10 minutes) is not 
at variance with these findings, since evidence has been presented (Grob, 1943) 
that  this  destruction is  due  to  the  denaturation by heat  of serum proteins 
(especially albumin),  to which  serum antiprotease is probably bound. 
(d)  Objections  to the Reducing  Agent-Sulfhydryl  Theory  of the Antiproteolytic 
Activity of the Serum,  and Further Work  That  Is lndicated.--More  convincing 
evidence for attributing the antiproteolytic activity of the serum to the action 
of sulfhydryl compounds would be the demonstration of inactivation of these 
compounds  by  mercaptide-forming  reagents  (e.g.  benzylmercuric  chloride, 
p-tolyl mercuric chloride, cuprous oxide), but not by symmetrically substituted 
mercury  compounds  (e.g.  mercury  di-p-tolyl),  which  cannot  convert  mer- 
captans  to  substituted  mercaptides.  These four  reagents  were  tested,  the 
mercury compounds in concentration of 1/50th saturation, and only the cuprous 
oxide was  found to inhibit  serum  antiprotease.  Table X  lists  some of  the DAVID GROB  239 
compounds which,  in the concentrations studied, had no observed  effect  on 
serum  antiprotease.  These  included three  inhibitors  of  sulfhydryl groups; 
namely the two mercaptide-forming mercury reagents and  sodium selenite. 
However, a wider range of concentration of these compounds must be tested 
before it can be said that they are not effective against serum antiprotease. 
Serum inhibits papain, though to a much lesser degree than it inhibits trypsin 
or leucoprotease.  The inhibition of papain must be explained by some other 
mechanism  than  sulfhydryl groups,  since  papain  is  activated  rather  than 
inactivated by sulhydryl compounds.  It is probable that the antiproteolytic 
activity of the serum is the sum of two or more factors, and at least one of 
these factors (ascorbic acid) inhibits papain in spite of the fact that it is a re- 
ducing agent that also  inhibits trypsin and leucoprotease. 
The sulfhydryl theory would be supported by demonstration of the reversi- 
bility of the inhibition of  serum  antiprotease.  Experiments were  planned: 
(a) to test the reversibility of the inhibition of serum antiprotease; (b) to test 
the reversibility of the inactivation of leucoprotease  and trypsin by reducing 
agents and  their  activation by oxidizing  agents;  (c)  to  study the possible 
inhibition of the trypsin inhibitors prepared from tryptic digests of proteins 
and from egg white, in a manner similar to the study of the inhibition of serum 
antiprotease; and (d) to study the antiproteases that might be prepared from 
leucoprotease digests of proteins.  However, time was not available for their 
execution. 
6. The Influence of pH on Leucoprotease,  Trypsin, Papain, and Serum 
A nt  i pr  otease 
Leucoprotease has long been known to have its optimum pH at 7,  trypsin 
at 8, and papain at 5 to 6.  Northrop (1922) has shown that the inhibition of 
trypsin by the products of tryptic hydrolysis of proteins is not affected by pH 
between 6 and 10.  Weiss (1927) has demonstrated that adjusting the reaction 
to a pH of 5 or less causes serum to lose its antitryptic power. 
The influence  of pH  on leucoprotease, trypsin, papain,  and serum anti- 
protease was studied by following the digestion of casein (nephelometrically) 
in media buffered at various pH values  The results are recorded in Tables 
XI and XII (and reproduced in Charts 3A, 3B, and 3C).  Chart 3A shows the 
activity of the three proteases at varying pH, and the optima are seen to be 
pH 8 for trypsin, pH 7 for leucoprotease, and pH 6 for papain, with  rather 
restricted range of activity for leucoprotease and trypsin.  Chart 3B shows the 
activity of the enzymes at various pH values in the presence of  serum (0.2 
per cent).  It is seen that the serum has markedly inhibited trypsin and leuco- 
protease, and has only slightly inhibited papain.  Furthermore the presence of 
serum has caused the pH optima of leucoprotease and trypsin to shift to the 
acid side, to a pH of 6 to 6.5, and it has caused the range of activity to widen 
slightly in both acid and alkaline reactions. 240  PROTEOLYTIC  ENZYMES.  I 
The reason for these latter changes is made clear by study of the effect of 
exposing serum to different pH values for 1 hour, then adjusting the reaction 
TABLE XI 
The Influence of pH on the Acbiz4ty of Leu~oprotease, Trypsin, and Papain, in the Absence of 
Serum and in tke Presence of Serum 
(The per cent of enzyme activity is recorded.) 
pH 
1.8 
3.1 
4.7 
6.0 
6.3 
6.5 
7.0 
8.0 
9.2 
9.5 
10.8 
Leucopro-  pH 
tease 
0  2.0 
0  3.5 
0  5.3 
60  5.8 
80  6.3 
88 
100  7.4 
80  8.0 
28  9.2 
0  9.8 
0  10.9 
Leucopro- 
tease 
+  0.2 
per cent 
seruln 
0 
0 
15 
35 
55 
37 
27 
14 
0 
0 
Crude 
pH  trypsin 
2.5  0 
4.1  0 
5.8  4 
6.5  70 
6.6  74: 
6.8  88 
7.4  98 
7.9  100 
8.6  80 
9.1  4 
9.3  0 
Crude 
trypsin 
pH  +0.02 
per cent 
2.1  0 
4.9  0 
5.4  3 
5.8  25 
6.3  36 
6.8  36 
7.4  29 
8.0  20 
9.1  12 
9.5  0 
pH 
2.0 
4.5 
5.6 
6.0 
6.3 
6.8 
7.4 
7.9 
9.2 
9.5 
PapaJn 
0 
68 
92 
1130 
95 
90 
74 
50 
0 
0 
pH  per cent 
serum 
3.3  8 
4.5  40 
5.6  51 
6.0  71 
6.7  83 
7.4  67 
8.0  56 
9.2  42 
10.0  0 
TABLE XII 
The Infl.uence oJ pH on the Antiproteolyti~ Actizqty of the Serum 
(Serum exposed to indicated pH for 1 hour, neutralized, added to digest mixture, and pro- 
tease action determined at pH 7.8.  The per cent of enzyme activity is recorded.) 
pH to which serum  Leucoprotease +0.1  Crude trypsin  +0.I  Papaln -{-0.1 
was exposed  per cent serum  per  cent  serum  per cent serum 
96  100  2.6 
3.7 
4.5 
5.9 
6.6 
7.4 
8.0 
9.7 
10.7 
11.2 
96 
91 
90 
85 
80 
80 
85 
95 
100 
97 
90 
85 
77 
75 
75 
80 
88 
100' 
100 
98 
96 
94 
94 
90 
90 
92 
94 
95 
back to neutral and adding the serum to digest mixtures (to reach a concentra- 
tion of 0.1 per cent), and determining the protease action (at pH 7.8).  The 
results of this procedure are reproduced in Chart 3C, which  shows that the 
antiproteolytic activity  of the  serum  (against  leucoprotease,  trypsin,  and DAVID GROB  241 
papain) is progressively weakened by exposure to hydrogen ion concentrations 
below pH 6.5 or above pH 9.7. 
-,  "-----. ......... 
so-  ~/ 
75/9o  (c) 
, "*",  ~  ~  T~'p  s  in 
80-  /  ~  e---  ----eLeueoprot ease 
70-  f  • •  4- ......  -~Papain 
oo-  /  •  ~. 
~  /\  "-. 
50"  .-  . 
40-  ""  f  " 
~  20.  ,~' 
10-  #'" 
o/1oo  Is) 
:  j  "-.~'~  \ 
,. ,o  ///~,  ,,\~iiit 
80"  jill II'/'f 
7~  ;1' 
60"50  ~  Ill Illlll 
40- 
i(>  ""i  (A) 
o  )'  l'lll.5 
2.5  5  4  5  6  7  pH  8  9  I0 
CHART 3.  A, the influence of pH on the activity of leucoprotease,  crude trypsin, 
and papain.  B, the influence of pH on the activity of leucoprotease,  crude trypsin, 
and papain in the presence of serum (0.2 per cent).  C, the influence of pH on the 
antiproteolytic  activity of serum (0.1 per cent).  (Serum exposed to indicated pH for 1 
hour, neutralized, added to digest mixture, and protease action determined at pH 7.8.) 
The activity of protease in the presence of serum and at various pH values 
will be directly proportional to the activity of the enzyme at any given pH, 
and inversely proportional to the activity of serum antiprotease at that pH. 
The resultant activity will be the summation of these two factors.  At neutral 242  PRO~OLYTIC ENZX~ES.  I 
pH leucoprotease and trypsin are most active, but serum antiprotease is also 
at its optimum activity.  At a pH of 6 to 6.5 the enzymes are somewhat less 
active, but the serum antiprotease is weakened to a greater degree, so that the 
resultant activity  in the presence of serum exceeds that at neutral pH.  At pH 
values below 6.5  and above 9.7 serum antiprotease is increasingly inactive, 
and the presence of serum may then actually help enzyme action by virtue of 
its  buffering power. 
The influence of pH on the antiproteolytic activity of the serum, and the 
influence of the presence  of serum on the pH optimum of leucoprotease,  are 
significant  because all three factors--leucoprotease, antiprotease, and hydrogen 
ion concentration--are variables of great importance wherever polymorphonu- 
clear leucocytes accumulate in the body.  The interplay of these factors may 
well explain many of the obscure phenomena of inflammation: for instance, to 
name only one, why proteolysis frequently proceeds more rapidly in exudates 
(especially  purulent  ones)  after  the  accumulation of  some  protein  digest 
products has rendered the medium more  acid than the optimal pH for leuco- 
protease activity. 
The hydrogen ion concentration not only exerts  a  direct influence on the 
activity of leucoprotease  and serum  antiprotease, but by shifting oxidation- 
reduction equilibria  exerts an additional and important indirect effect.  The 
sensitivity of  oxidation-reduction potentials to  hydrogen ion  concentration 
has been fully demonstrated by Clark and his coworkers  (1928). 
D. THE CONTROL OF TIIE  ACTIVITY OF LEUCOPEPTIDASE (EXPERIM'ENTAL DATA) 
Peptidase activity  has been found in extracts  of human polymorphonuclear 
leucocytes (Husfeldt, 1931).  Human  serum has also been found to contain a 
small amount of active peptidase (Jobling and Strouse, 1912).  It is claimed 
(Jobling, Petersen, and Eggstein, 1915) that serum possesses  no antipeptidase 
activity. 
In view of the physiological significance of the enzymes of the polymorphonu- 
clear leucocytes,  the control of  the activity of  the peptidase  of  these  cells 
("leucopeptidase") was  studied.  It was  originally intended to repeat  with 
leucopeptidase the experiments described above (performed with leucoprotease). 
However time permitted only a few preliminary experiments  on the control of 
the activity of leucopeptidase,  and of pancreatic peptidase (in crude trypsin). 
Leucopeptidase  and  pancreatic  peptidase  activity  were  determined  by 
adding glycerol extracts of cat polymorphonuclear leucocytes  (the "leucopro- 
tease" described above),  and crude trypsin (Fairchild,  beef) to a substrate of 
peptic digest of edestin (prepared  after Anson,  1937), stopping the digestion 
after a given time by the addition of formaldehyde, and finally adding phenol- 
phthalein and determining how much sodium hydroxide was needed  to make 
the solution as pink as a  standard solution.  The titration was begun with DAVID GROB  243 
strong alkali and completed with 0.02  N NaOH, fn terms of which the results 
are recorded.  This was done in order to avoid increasing the volume, which 
would  produce  the  so  called  "water  error"  (Harris,  1923). 
TABLE XIII 
Prdiminary  Experiment on the Influence of Reducing and Other Substances on Leucopeptidase 
and Pancreatic Peptidase 
(Enzyme activity is recorded as the cubic centimeters of 0.02N NaOH (or its equivalent) 
required to titrate digest mixture of 8 cc. peptic digest of edestin +  1 cc. enzyme +  1 cc. 
substance to be tested, after 20 hours incubation at 37°C. under toluene. 
Substance  Concentration  in  Pancreatic 
digest  mixture  Leucopeptidase  peptidase 
gm./lO0 co. 
None (control) ..................... 
Cysteine  ........................... 
Ascorbic acid ...................... 
Serum ............................ 
Sulfathiazole  ....................... 
Thiourea .......................... 
0.03 
0.05 
1.0 (per cent) 
0.010 
0.50 
3.0 
5.2 
6.3 
4.0 
3.1 
2.5 
4.0 
5.6 
7.4 
4.8 
3.9 
2.8 
TABLE XIV 
Summary of tke Influence of Reducing and Oxidizing Agents on the Systems Studied 
Source 
Polymorph. leucocytes 
Pancreas. 
Papaya plant. 
¢,  c, 
Serum. 
Enzyme 
•  Leucoprotease 
Leucopeptidase 
Trypsin (pro° 
teinase) 
Erepsin (pep- 
tidase) 
Papain proteinase 
"  peptidase 
Eseyme i~ldbltor 
Antiprotease 
Influence of reducing 
agents 
+ 
m 
+ 
+ 
--  (Bergmann and 
collaborators, 
1935-36) 
-{- (Additive) 
Influence of oxidizing 
agents 
+ 
(Not studied) 
+ 
(Not studied) 
q- (Bergmann and 
collaborators, 
1935-35) 
+  ffi increased activity. 
-- ffi decreased activity. 
The influence of cysteine, ascorbic acid, serum  (human),  sulfathiazole, and 
thiourea  on  leucopeptidase  and  pancreatic  peptidase was  studied.  Results 
are recorded in Table XIII.  The few experiments that were performed indi- 
cate that extracts of cat polymorphonuclear leucocytes contain active pepti- 
dase,  and  that  the  activity of  this  leucopeptidase, as  well as  of  pancreatic 244  PROTEOLYTIC  ENZYMES.  I 
peptidase, is increased by reducing agents such as cysteine and ascorbic acid, 
and is not influenced appreciably by serum, sulfathiazole,  or thiourea.  (The 
slight increase in activity caused by serum may be due to serum peptidase.) 
The presence in extracts of polymorphonuclear leucocytes and of pancreas 
of proteinase (leucoprotease and trypsin) which is inhibited by reducing agents, 
and of peptidase (leucopeptidase and erepsin)  which is activated by reducing 
agents, recalls another reciprocal relationship in the control of the activity of 
proteinase and peptidase: namely, the presence in crude papain preparations of 
proteinase which is activated by reducing agents and peptidase  (Bergmann 
and collaborators,  1935-36)  which is inactivated by reducing agents.  Table 
XIV lists these enzymes (and serum antiprotease) and summarizes the influence 
of reducing and oxidizing agents.  The reciprocal relationships that exist in 
the control of these enzyme systems are no doubt significant  physiologically, 
and perhaps teleologically  as well. 
S~ARY 
I.  The literature on conditions affecting the activity of proteolytic enzymes 
has been reviewed. 
2.  Experimental data on the control of the activity of trypsin, leucoprotease, 
papain,  serum antiprotease,  leucopeptidase, and  pancreatic peptidase  have 
been presented.  These data indicate that: 
(a) The polymorphonuclearleucocytes  of the cat contain abundant proteinase 
and peptidase active at neutral pH; those of the rabbit lack proteinase active 
at neutral pH. 
(b) Reducing agents, including several biologically important thiol-sulfhydryl 
compounds and ascorbic acid, inhibit the activity of leucoprotease and trypsin. 
For each reductant the degree of inhibition is proportional to the reducing 
capacity of the medium. 
(c) p-Aminobenzoic  acid, sulfonamides. (especially sulfathiazole), and many 
diphenyl sulfones inhibit the activity of leucoprotease. 
(d)  Serum,  plasma,  several heavy  metals,  ammonium  salts,  asparagine, 
thiourea, heparin, glutamic acid, tyrothricin, calcium chloride,  and bile salts 
and bile acids also inhibit the activity of leucoprotease, and in most cases of 
trypsin too. 
(e) Preparations of tryptic digests of proteins, and egg white trypsin inhibitor, 
inhibit trypsin to a much greater degree than leucoprotease. 
(f) Mild oxidizing agents increase the activity of leucoprotease and trypsin. 
(g)  Oxidizing agents and some inhibitors of sulfhydryl groups inhibit  the 
antiproteolytic activity of the serum.  It is suggested that serum antiprotease 
may consist (chiefly)  of reducing agents, including thiol-sulfhydryl peptides 
which exert their antiproteolytic activity by virtue of the presence of sulfhydryl 
groups. DAVID GROB  245 
(h)  The antiproteolytic activity of the serum is progressively weakened by 
exposure  to  a  hydrogen  ion  concentration  below pH  6.5  or  above pH  9.7. 
Because of this the pH optima of leucoprotease and trypsin are shifted in the 
presence of serum from pH of 7 and 8 to pH of 6 to 6.5, and the range of activity 
of these enzymes is slightly widened, in both acid and alkaline reactions. 
(i)  Reducing agents increase  the activity of leucopeptidase and pancreatic 
peptidase.  Serum,  sulfathiazole,  and thiourea have little or no effect. 
3.  The significance of the oxidation-reduction  system in the control of the 
activity  of  leucoprotease,  trypsin,  serum  antiprotease,  leucopeptidase,  and 
pancreatic peptidase has been emphasized. 
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